Weekly islatravir plus lenacapavir maintains HIV virologic suppression
1. In this randomized controlled trial, once-weekly oral islatravir (ISL) plus lenacapavir (LEN) maintained high rates of HIV-1 virologic suppression ...
Tag: human immunodeficiency virus (HIV)
Ending Ryan White services may increase human immunodeficiency virus incidence
1. In this simulation study involving persons with human immunodeficiency virus living in the United States, ending Ryan White services ...
Anal cancer screening cost-effective for men who have sex with men with human immunodeficiency virus aged above 35 years
1. In this microsimulation model, initiation of anal cancer screening in men who have sex with men with human immunodeficiency ...
Safety of investigational vaccines against human immunodeficiency virus
1. In this phase 1 randomized controlled trial, urticaria was reported in several participants who received a messenger RNA vaccine ...
#VisualAbstract: Twice-Yearly Lenacapavir is Effective for Human Immunodeficiency Virus Prevention in Men and Gender-Diverse Persons
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Kidney Transplantation from Donors with Human Immunodeficiency Virus (HIV) is Non-inferior to Donors Without HIV
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without ...
Pitavastatin reduces cardiovascular event risk among patients with HIV
1. In this randomized controlled trial, among patients living with human immunodeficiency virus (HIV) at low-to-moderate risk of cardiovascular disease, ...
#VisualAbstract: Dolutegravir noninferior to a ritonavir-boosted protease inhibitor regimen for treating HIV
1. In the randomized controlled trial, dolutegravir treatment was noninferior to a regimen containing a ritonavir-boosted protease inhibitor (PI) for ...
Dolutegravir noninferior to a ritonavir-boosted protease inhibitor regimen for treating HIV
1. In the randomized controlled trial, dolutegravir treatment was noninferior to a regimen containing a ritonavir-boosted protease inhibitor (PI) for ...
Doxycycline postexposure prophylaxis reduces the incidence of bacterial sexually transmitted infections
1. In this randomized trial, postexposure prophylactic doxycycline significantly reduced the incidence of sexually transmitted infections (STIs) in men who ...
